Lupin Receives FDA Approval for New Cholesterol Drug

Lupin has received an FDA approval for its cholesterol drug, Nikita Pitavastatin. The drug, which received a new drug approval from the agency, is poised as the latest treatment for patients suffering from primary hyperlipidemia or mixed dyslipidemia by lowering total...

FDA Previews Digital Health FastTrack Program

The FDA unveiled its program for digital health approvals this week. Named the Digital Health Innovation Action Plan, the program aims to speed up approval processes for digital health software which functions differently and poses a lower risk to health than medical...

Trump to Decide on Long Awaited Insurance Subsidies

President Trump has confirmed that he will decide whether to fund cost-sharing subsidies for lower-income Americans on Obamacare. The subsidies would offset high medical bills, enabling more Americans to afford their healthcare. A decision against funding the...